Modernising Pharma Manufacturing with co-innovation

0
Envision a pharmaceutical plant where people are watchful and attentive as the business responds to change quickly and efficiently. As digital transformation ensues to disrupt, transform and reshape industries we can now picture an operation that delivers consistent production, real-time information and accurately controlled and safe processes that comply to the regulatory and demanding requirements of the pharmaceutical...

Panel finds dosing mismatches in many FDCs

0
New Delhi: The expert panel which recommended a continuation of the ban on fixed dose combinations (FDCs) has found that many FDCs were formulated without due diligence, with dosing mismatches that could result in toxicity. Panel finds dosing mismatches in many FDCs The committee found that most pharma companies had not generated the “safety and efficacy data” of...

Dr Reddy’s gains over 1% ahead of June quarter results announcement

0
Shares of Dr Reddy’s Laboratories gained over a percent on Thursday morning as investors bet on the stock ahead of Q1 results. The numbers will be declared later in the day. The stock touched an intraday high of Rs 2,118.45 and an intraday low of Rs 2,075.60. The drug maker is likely to report a four-fold jump in the first...

Panel reviewing efficacy of 349 FDCs may reinforce ban

0
New Delhi: Pharmaceutical companies awaiting report on the safety of those fixed dose combinations (FDCs) that were earlier banned by the ministry of health and family welfare are unlikely to get a breather. The expert panel probing the efficacy of 349 (344+5) banned FDCs is likely to reinforce the ban. According to the people with knowledge of the development,...

375 grams to 2.4 Kg: Smallest baby ever born in India survives, thrives

0
Her name is Cherry and she is the smallest baby ever born in India. At birth, she was just about 26 cms in length – that is about the size of your palm — and weighed 375 grams, making her perhaps the smallest not just in India but in the whole of South Asia. Normally, babies...

Aurobindo takes over Apotex operations in five European countries for 74 million euros

0
Hyderabad-based Aurobindo Pharma has inked a definitive agreement with Canadian pharmaceutical firm Apotex to take over its commercial operations in five European countries. The two pharma players signed an all-cash deal amounting to 74 million euros, under which Aurobindo’s step-down subsidiary Agile Pharma B V will acquire commercial businesses of Apotex and some supporting infrastructure, according to a...

Sun Pharma unit files patent case against German firm

0
New Delhi: DUSA Pharmaceuticals, a unit of Sun Pharmaceutical Industries, has filed a trade secret misappropriation and tortious interference claim against Biofrontera Inc. in the district court of Massachusetts, the company said in a statement. The lawsuit alleges patent violation of topical solution Levulan, and Kerastick. DUSA has also alleged that the Germany-based Biofrontera improperly obtained confidential information from...

Cadila Healthcare stock erases opening gains, Zydus gets USFDA nod for oral iron chelator

0
Cadila Healthcare share price erased opening gains after rising more than a percent due to tentative approval from the US health regulator for the oral iron chelator. The company in its filing said its group company Zydus has received tentative approval from the US Food and Drug Administration for Deferasirox. Cadila Healthcare stock erases opening gains, Zydus gets...

China agrees to cut tariffs on Indian cancer drugs

0
China said on Monday it had reached an agreement with India to reduce tariffs and increase imports of Indian medicines, particularly anti-cancer drugs, part of moves to broaden its trade relations amid its on-going spat with the United States. Both India and China slashed import tariffs of a range of products starting July 1, following the fourth round...

Dr Reddy’s Laboratories up 3% on agreement with UCB to distribute Briviact in India

0
Share price of Dr Reddy’s Laboratories added 3 percent intraday Monday as company entered in to distribution and co-promotion agreement with UCB. The company has entered into a distribution and co-promotion agreement with UCB for Briviact, a brand of brivaracetam. The agreement grants company the exclusive right to distribute Briviact in India. Briviact is approved as an adjunctive therapy for...